JPX Equity Snapshot

4503 Weekly Equity Report

Astellas Pharma Inc.

Interactive chart JSON snapshot
Latest Close 2,140 JPY 12 Jun 2026
1W Return -1.0% latest completed week
4W Return -7.9% short-term follow-through
12W Return -8.8% quarterly tape
Trend Breadth 82.7% 43 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
Company Brief

What the company does

Astellas Pharma Inc. manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally. The company offers XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for acute myeloid leukemia; VYLOY, a treatment for gastric cancer; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also provides VEOZAH, a treatment for vasomotor symptoms due to menopause; IZERVAY, a treatment for geographic atrophy secondary to age-related macular degeneration; EVRENZO, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf, an immunosuppressant. It has a research collaboration with xFOREST …

Snapshot

What the weekly tape is saying

4503 closed the latest completed week at 2,140 JPY. The 4-week return is -7.9% and the 12-week return is -8.8%. Trend Signal is inactive, Market Dynamics is -1.03. Setup signature: Risk-first tape with a 31/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -5.9%
Volume 1.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 45 Persistence of active Trend Signal over the last year and current streak.
Momentum 24 Blend of 4-week and 12-week follow-through.
Dynamics 31 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 50 Participation compared with the 13-week volume baseline.
Risk Control 35 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
2,274 JPY
Vs Trend Line
-5.9%
Fair Value
1,687 JPY
Vs Fair Value
26.9%
52W High
2,717 JPY
52W Low
1,292 JPY
Drawdown
-21.2%
Range Position
59.5%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -1.0%
4W -7.9%
12W -8.8%
26W 5.7%
52W 60.3%

Trend read

Active Streak
0 weeks
52W Active Weeks
43
52W Active Breadth
82.7%
Sector Scope
JP Healthcare
Sector Rank
101 of 223
Sector Percentile
55.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.03
4W MD Change
-2.7%
Relative Strength
-15.48
4W RS Change
-812.2%
Expectation
Undecided
Probability
46.40%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
35.1M
13W Average
29.2M
52W Average
33.2M
Vs 13W
1.2x
Vs 52W
1.1x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.6%
52W Volatility
4.2%
Upside Weeks
31
Downside Weeks
20
Downside Breadth
38.5%
Avg Gain / Loss
3.4% / -2.6%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
JPX
Country
JP
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
JPY
Market Cap
4090.0B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 2,140 JPY -1.0% 2,274 JPY 1,687 JPY -1.03 -15.48 35.1M Off
5 Jun 2026 2,161 JPY -5.3% 2,265 JPY 1,686 JPY -1.05 -15.50 31.6M Off
29 May 2026 2,283 JPY 0.6% 2,250 JPY 1,685 JPY -1.07 -10.52 45.7M On
22 May 2026 2,270 JPY -2.4% 2,227 JPY 1,683 JPY -1.13 -6.94 26.0M On
15 May 2026 2,324 JPY 1.1% 2,205 JPY 1,682 JPY -1.00 -1.70 26.9M On
8 May 2026 2,300 JPY 4.2% 2,180 JPY 1,680 JPY -0.76 -4.61 25.0M On
1 May 2026 2,207 JPY -10.6% 2,156 JPY 1,677 JPY -0.40 -3.50 38.8M On
24 Apr 2026 2,468 JPY -3.3% 2,136 JPY 1,675 JPY -0.06 7.49 18.8M On
17 Apr 2026 2,554 JPY -2.1% 2,107 JPY 1,670 JPY 0.24 13.81 23.1M On
10 Apr 2026 2,607 JPY 0.8% 2,075 JPY 1,665 JPY 0.22 19.73 24.9M On
3 Apr 2026 2,587 JPY 0.6% 2,042 JPY 1,660 JPY 0.25 27.92 29.2M On
27 Mar 2026 2,570 JPY 9.6% 2,010 JPY 1,654 JPY 0.41 27.10 32.2M On
20 Mar 2026 2,346 JPY 0.9% 1,976 JPY 1,648 JPY 0.59 16.60 22.7M On
13 Mar 2026 2,326 JPY -1.8% 1,953 JPY 1,643 JPY 0.93 15.03 32.7M On